![Doron Cohen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Doron Cohen
Financieel Directeur/CFO bij
GALMED PHARMACEUTICALS LTD.
Vermogen: 12 278 $ op 30-06-2026
Profiel
Doron Cohen currently works at Galmed Pharmaceuticals Ltd., as Chief Financial Officer from 2022 and OnKai, Inc., as Chief Financial Officer from 2023.
Mr. Cohen also formerly worked at Tangram Strategic Ltd., as Chief Executive Officer, Gems Investment Research Ltd., as Research Director from 1992 to 2017, and World Union of Jewish Students, as Director-Public Relations from 1990 to 1992.
Mr. Cohen received his graduate degree from Boston University and undergraduate degree from The University of New South Wales.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-03-2026 | 22.083 ( 0,33% ) | 12 278 $ | 30-06-2026 |
Actieve functies van Doron Cohen
| Bedrijven | Functie | Begin |
|---|---|---|
| GALMED PHARMACEUTICALS LTD. | Financieel Directeur/CFO | 01-02-2022 |
Onkai, Inc.
 Onkai, Inc. Packaged SoftwareTechnology Services Develops an AI-based platform that helps local health care professionals | Financieel Directeur/CFO | 01-10-2023 |
Eerdere bekende functies van Doron Cohen
| Bedrijven | Functie | Einde |
|---|---|---|
Gems Investment Research Ltd. | Corporate Officer/Principal | 01-01-2017 |
Tangram Strategic Ltd. | Algemeen Directeur | - |
Opleiding van Doron Cohen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
6
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galmed Pharmaceuticals Ltd.
 Galmed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures aramchol for non-alcoholic steatohepatitis | Health Technology |
Gems Investment Research Ltd. | |
Onkai, Inc.
Onkai, Inc. Packaged SoftwareTechnology Services Develops an AI-based platform that helps local health care professionals | Technology Services |
Tangram Strategic Ltd. |
